Clinical Trial Detail

NCT ID NCT02435121
Title A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification
Recruitment Completed
Gender
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications

lung non-small cell carcinoma

Therapies

SAR125844

Age Groups: adult

No variant requirements are available.